LXEO: Lexeo Therapeutics Net earnings per share for the last 12 months

LXEO (Lexeo) - company brandmark

The DNA technology sector is currently experiencing a boom in genetic discoveries, and Lexeo Therapeutics (LXEO) is actively developing its pipeline of Alzheimer's treatments. The company's revenues are based on partnership payments and future licenses, while vector production and testing are fully outsourced to third-party contractors. Fundamental TTM earnings per share reflect a yield trend, with the current level sitting around -1.15.

LXEO (Lexeo) Earnings per share for the trailing year history from 02/21/2024 to 11/14/2026

Analytical breakdowns for Lexeo (LXEO)

- share price and expert price forecast:
Stock Quotes Lexeo Therapeutics, Inc.|LXEO - Fair Value Consensus
- market capitalization information:
Market Valuation Lexeo Therapeutics, Inc.|LXEO - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Lexeo Therapeutics|LXEO - Accounting Value of Company|Market Capitalization to Book Value Ratio lexeotx.com|LXEO - Company Assets
- business debt structure and liquidity details:
Debt to Equity Lexeo Therapeutics|LXEO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Lexeo Therapeutics|LXEO - Company Aggregate Debts|Debt to Book Capitalization Ratio Lexeo Therapeutics Inc.|LXEO - Long-Term Liabilities|Company Short-Term Debts Lexeo Therapeutics|Quick Liquidity Indicator lexeotx.com
- net income and valuation multiples indicators:
LXEO - Net Profit|Future Profit Lexeo Therapeutics|LXEO - Market Price to Net Income Ratio|Forward P/E Multiple Lexeo Therapeutics Inc.|LXEO - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Lexeo Therapeutics, Inc.|LXEO - Operating profit before deduction of amortization|Earnings per share for the last twelve months Lexeo Therapeutics|LXEO - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months lexeotx.com|LXEO - Earnings per share growth in current year|Expected earnings per share growth for next year Lexeo Therapeutics
- issuer revenue and sales details:
LXEO - Company Sales Volume|Projected Sales Volume Lexeo|LXEO - Price to Sales|Price-to-Projected Revenue Ratio Lexeo Therapeutics, Inc.
Analysis of all company metrics:LXEO - Lexeo Therapeutics, Inc.
Mass-produced product of Lexeo Therapeutics Inc.

This indicator is calculated as the ratio of total annual net income to the total number of shares outstanding, measuring the actual return on a single share of capital. The growth of the rolling 12-month EPS confirms the ability of Lexeo Therapeutics (LXEO) to monetize R&D developments in genetic medicine, converting scientific potential into financial stability and a hedge against inflationary costs.

Key competitors

TEM: Net earnings per share for the last 12 months|QGEN (Qiagen Group) - Earnings per share for the last 12 months|Ionis (IONS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Net earnings per share (EPS TTM)|CRSP (CRISPR Therapeutics AG) - Earnings per share for the last four quarters|Earnings per share for the last twelve months GeneDx (WGS)|RARE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BEAM (Beam Therapeutics Inc)|Earnings per share for the trailing year SRPT|twistbioscience.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TXG (10x Genomics, Inc.)|NTLA: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months STOK (Stoke Therapeutics, Inc.)|Net earnings per share for the last 12 months BLFS|Net earnings per one share for the last twelve months Wave Pharma WVE|Net earnings per share for the last 12 months MAZE (Maze Tx)|SION - Net earnings per one share for the last twelve months|Prime Medicine - Net earnings per share for the last 12 months|Taysha Gene Therapies Inc (TSHA) - Net earnings per one share for the last twelve months|uniqure.com - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year MeiraGTx Corp (MGTX)|REGENXBIO (RGNX) - Earnings per share for the last twelve months|SLDB - Net earnings per share for the last four quarters|OCGN (ocugen.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Pacific Biosciences of California, Inc. PACB|Net earnings per share (EPS TTM) BNTC|Net earnings per share for the last four quarters Design Pharma|Net earnings per share (EPS TTM) RCKT (Rocket Corp)|FDMT - Net earnings per share for the last 12 months|Korro Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Editas Medicine|Silence Therapeutics (SLN) - Earnings per share for the last twelve months|PRQR (ProQR Therapeutics N.V.) - Earnings per share for the last twelve months|CDXS (Codexis Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months sangamo.com (SGMO)|Net earnings per share (EPS TTM) NAUT|Net earnings per share (EPS TTM) Metagenomi (MGX)|Earnings per share for the last twelve months Precision BioSciences DTIL|Net earnings per share (EPS TTM) Generation Bio Corp GBIO|Boundless Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Exicure Inc.|Imunon, Inc. (IMNN) - Earnings per share for the last twelve months|RXi Pharmaceuticals (PHIO) - Net earnings per share (EPS TTM)|MBIO (Mustang Bio Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months RNAZ (TransCode Therapeutics)|Net earnings per share (EPS TTM) BNGO|APDN: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) BLUE (bluebird bio Inc.)|Net earnings per share for the last four quarters ImmunoPrecise Antibodies (IPA)|OMGA: Net earnings per share for the last 12 months|OMIC (Singular Genomics Systems Inc) - Earnings per share for the last 12 months|Regulus Therapeutics (RGLS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months syros.com (SYRS)|TBIO (Telesis Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months TRACON Pharmaceuticals Inc. (TCON)|Net earnings per share for the last 12 months UBX (Unity Biotechnology, Inc.)